Name: In Vitro Transcription Assays and Their Application in Drug Discovery (Video) | JoVE Journal
Uploaded: 2016-09-20T08:00:00.000+00:00
Duration: 9 min 28 s
Description: Learn in vitro transcription assays for studying bacterial transcription regulation and testing antibacterial agents. This method enables direct visualization of RNA products to evaluate inhibitor effects.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work acknowledges a Faculty Early Career Grant from the University of Newcastle (CM).

Caution: Experiments involve the use of the radioactive isotope 32P and no work should be undertaken until all appropriate safety conditions have been met. Generally personnel are required to attend a safety course and undergo supervised practice prior to experiments using radioactive reagents. Please wear personal protection equipment (thermoluminescent dosimeter, safety glasses, gloves, radiation room lab coats, full length pants, closed-toe shoes) when performing the reaction.
1. Preparation of Assay Materials
<ol>
	<li>Obtain the Proteins Required for Transcription assay.
	<ol>
		<li>For the experiment described here, overproduce and purify E. coli RNAP in the laboratory as described11, or obtain from a commercial source (Materials List). 
		Note: Both provide similar results. Other methods for purification of native or affinity labeled RNAP can also be used12,13. Sigma/NusA factors can be obtained as described in previous work14,15.</li>
	</ol>
	</li>
	<li>Preparation of Diethyl Pyrocarbonate (DEPC) Treated Water 
	Note: Alternatively, RNase-free water can be obtained from commercial sources (Materials List).
	<ol>
		<li>Add 1 ml diethyl pyrocarbonate (DEPC) to 1 L of purified water (0.1% v/v) and mix overnight.</li>
		<li>Autoclave DEPC water and tips twice.</li>
	</ol>
	</li>
	<li>DNA Template Preparation
	<ol>
		<li>Purify plasmid pSG115416 and/or pIA22617 using a plasmid purification kit (Materials List) according to manufacturer&#39;s instructions.</li>
		<li>To amplify the template for run-off transcription assays (a 360 bp fragment encompassing the Pxyl promoter region), assemble a PCR reaction on ice including 25 &#956;l 2x PCR mix (Materials List), 2 &#956;l each of the primers (5 &#181;M): 5&#8242;-CAAAGCCTGTCGGAATTGG-3&#8242; (forward) and 5&#8242;-CCCATTAACATCACCATC-3&#8242; (reverse), 1 &#956;l pSG1154 plasmid preparation (250 &#181;M) and 20 &#956;l purified water).
		<ol>
			<li>Or alternatively, for single round transcription assays, amplify a 447 bp fragment encompassing the &#955; PR promoter region from pIA22617. Set up a PCR reaction on ice using 25 &#956;l 2x PCR mix, 2 &#956;l each of the primers (5 &#181;M): 5&#8242;-GTGCTCATACGTTAAATCT-3&#8242; (forward) and 5&#8242;-CAGTTCCCTACTCTCGCATG-3&#8242; (reverse), 1 &#956;l pIA22617 plasmid preparation (250 &#181;M) and 20 &#956;l purified water). 
			Note: This template lacks cytosine until the +26 nt position, which is the 26th nucleotide from the transcription start site. Therefore, transcription using this template will allow initiation, promoter clearance and stalling at the +26 nt to form a stable transcription elongation complex (EC) when only ATP, UTP and GTP are present in the reaction.</li>
		</ol>
		</li>
		<li>Set up a PCR reaction with the following conditions: 95 &#176;C for 30 sec, 50 &#176;C for 30 sec, 72 &#176;C for 30 sec, repeating for 30 cycles.</li>
		<li>Purify the product using a PCR clean-up kit (Materials List) according to manufacturer&#39;s instructions and elute in 100 &#956;l transcription buffer for the transcription assay.</li>
		<li>Determine the template DNA concentration using a fluorospectrometer (Materials List).</li>
	</ol>
	</li>
	<li>NTP Preparation 
	Note: NTPs can be obtained from different commercial sources (Materials List).
	<ol>
		<li>Dissolve NTPs (&#8805;99% pure) in DEPC-treated water to make 1 M stock, aliquot 1 ml of the solution into 1.5 ml tubes (50 &#956;l in each tube) and store at -20 &#176;C.</li>
		<li>Order &#945;-32P UTP (3,000 Ci/mmol) prior to the experiment. 32P has a short half-life of 14.29 days. 
		Note: Using alpha-labeled UTP avoids comparing the intensity of bands with different length.</li>
	</ol>
	</li>
	<li>RNA Ladder Preparation
	<ol>
		<li>Assemble the following reaction at room temperature: 0.5 &#956;g RNA Template Mix (Materials List), 80 mM HEPES buffer pH7.5, 12 mM MgCl2, 10 mM NaCl, 10 mM DTT, 2 mM ATP/CTP/GTP, 0.5 mM UTP, 2 &#956;l &#945;-32P UTP, 0.5 &#956;l T7 RNAP (Materials List), DEPC-treated water to 20 &#956;l.</li>
		<li>Allow reaction to proceed at 37 &#176;C for 1 hr. Use immediately or store at -80 &#176;C.</li>
	</ol>
	</li>
</ol>
2. Preparation of RNA Sequencing Gel
<ol>
	<li>Gel Preparation
	<ol>
		<li>Clean the plates from a sequencing gel apparatus (Materials List) twice with 70% ethanol and purified water, and assemble the cell with a comb and two spacers. 
		Note: One plate can be coated with siliconizing reagent (Materials List) to facilitate gel removal in Step 4.2.</li>
		<li>Dissolve 33.6 g urea in 22 ml water and 16.4 ml of 5x Tris/Borate/EDTA (TBE) buffer (54 g tris(hydroxymethyl)aminomethane; 27.5 g boric acid; 10 ml of 1 M ethylenediaminetetraacetic acid (EDTA), pH 7.4 in 1 L water) using a magnetic stirrer.</li>
		<li>Add 16 ml of 40% Acrylamide/bis-acrylamide solution (19:1) to the urea solution and filter through a 0.45 &#181;m filter.</li>
		<li>Add 514 &#181;l 10% (w/v) freshly prepared ammonium persulfate in water followed by 51.4 &#181;l N,N,N&#8242;,N&#8242;-Tetramethylethylenediamine (TEMED) to the filtered solution.</li>
		<li>Gently invert the gel solution to avoid excessive aeration and inject immediately and smoothly into the horizontally positioned pre-packed sequencing cell from the bottom injection hole. Take care to avoid making bubbles during injection.</li>
		<li>Allow 1-1.5 hr until the gel is completely set before use in a transcription assay. The gel can be stored at room temperature for two or three days when wrapped with water-wet tissue on the top of the sequencing cell.</li>
	</ol>
	</li>
</ol>
3. Transcription Reaction
<ol>
	<li>Transcription Elongation Pausing Assay
	<ol>
		<li>Formation of a transcription elongation complex
		<ol>
			<li>Add 1 &#181;l of RNAP core enzyme (1 &#181;M stock in transcription buffer) to a 1.5 ml tube.</li>
			<li>Add 1 &#181;l of purified sigma-70 factor (&#963;70; 3 &#181;M stock in transcription buffer) to the RNAP and incubate on ice for 10 min to form RNAP holoenzyme.</li>
			<li>Add 3 &#181;l 500 nM purified template DNA (&#955; PR promoter from the pIA226 PCR product) in transcription buffer to the RNAP holoenzyme and incubate at 37 &#186;C for 5 min to form the open complex.</li>
			<li>Prepare a mixture of reaction components in another 1.5 ml tube using 5 &#181;l of 10x transcription buffer (Materials List: 400 mM Tris-HCl, 1.6 M KCl, 100 mM MgCl2, 10 mM DTT, 50% glycerol, pH 7.9 in DEPC treated water), 2 &#181;l of 250 &#181;M each GTP and UTP, 1 &#181;l of 1 mM ATP, and 1 &#181;l of &#945;-32P UTP (3,000 Ci/mmol). Add DEPC treated water to 41 &#181;l. 
			Note: RNase inhibitor (Materials List) can be used to minimize the RNase contamination.</li>
			<li>Transfer the mixture solution to the tube containing the open complex and incubate at 37 &#186;C for 15 min to form the transcription elongation complex stopped at +26 nt.</li>
			<li>Move the reaction to room temperature (~21 &#176;C) and add 1 &#181;l of 2.5 mg/ml rifampicin to a final concentration of 50 &#181;g/ml.</li>
			<li>Add 1 &#181;l of 0.1 mM purified NusA to the reaction mixture and incubate for 5 min at room temperature.</li>
			<li>Add 2 &#181;l of 250 &#181;M CTP into the reaction mixture to make a final volume of 50 &#181;l and measure the reaction time using a timer.</li>
			<li>Transfer 5 &#181;l of the reaction solution into 2 &#181;l of RNA gel loading buffer (95% formamide, 0.05% bromophenol blue and 0.05% xylene cyanol) at 30, 60, 120, 240, 480, and 1,200 sec to quench the reaction.</li>
			<li>Dispose the 32P UTP tips and tubes in a radioactive waste container.</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Transcription Initiation Assay
	<ol>
		<li>Formation of the Open Complex&#160;
		<ol>
			<li>Dilute purified &#963;70 to 0.5 &#181;M.</li>
			<li>Repeat Steps 3.1.1.1 to 3.1.1.3 using 0.5 &#181;M (instead of 3 &#181;M) purified &#963;70, and the DNA template (the Pxyl promoter region from pSG1154 PCR product).</li>
		</ol>
		</li>
		<li>Inhibition of transcription initiation assay
		<ol>
			<li>Add the inhibitor designed to prevent RNAP holoenzyme formation to RNAP core enzyme prior to addition of &#963;70 (after step 3.1.1.1), followed by Steps 3.1.1.2 and 3.1.1.3 to examine whether the inhibitor is able to disrupt holoenzyme formation.</li>
			<li>Alternatively, after Step 3.1.1.2, add the inhibitor to examine whether it is able to competitively inhibit &#963;70 binding to RNAP.</li>
			<li>Use the same amount of DMSO, the solvent of the inhibitor, instead of the inhibitor stock in control reactions.</li>
		</ol>
		</li>
		<li>Completion of the reaction
		<ol>
			<li>Dissolve heparin in water to a stock concentration of 1 mg/ml and stock at -20 &#176;C. 
			Note: Heparin is a competitor of DNA that can sequester RNAP that has not formed an open complex. Once the open complex is formed, heparin cannot enter the DNA binding site of RNAP and inhibit transcription from pre-formed open complex. Therefore, heparin is only required for single-round assays; it is not needed for multi-round assays.</li>
			<li>Prepare the reaction mixture using 5 &#181;l of 10x transcription buffer (Materials List), 1 &#181;l of 1 mg/ml heparin solution, 1 &#181;l of 10 mM each ATP, GTP, and CTP, 2.5 mM UTP, and 1 &#181;l of &#945;-32P UTP (3,000 Ci/mmol). Add DEPC treated water to 45 &#181;l.</li>
			<li>Mix the reaction mixture with the transcription open complex, pulse spin and incubate at 37 &#176;C for 20 min.</li>
			<li>Transfer 10 &#181;l of the reaction solution into 5 &#181;l of RNA gel loading buffer (95% formamide, 0.05% bromophenol blue and 0.05% xylene cyanol) to quench the reaction.</li>
		</ol>
		</li>
	</ol>
	</li>
</ol>
4. RNA Gel Running and Development
<ol>
	<li>Running the Denaturing Polyacrylamide Gel
	<ol>
		<li>Run the gel at 50 &#186;C and 50 W in 1x TBE buffer for approximately 1.5 hr until the temperature of the gel and the buffer is stable at 50 &#186;C.</li>
		<li>Heat samples at 90 &#186;C for 30 sec and move them onto ice prior loading onto the gel.</li>
		<li>Load samples into the wells on the top of the gel alongside one lane containing 2 &#181;l RNA ladder (1:100 dilution).</li>
		<li>Run the gel at 50 W and 50 &#186;C in 1x TBE buffer until the bromophenol blue dye reaches ~2/3 down the gel.</li>
	</ol>
	</li>
	<li>Gel Treatment
	<ol>
		<li>Open slowly and carefully separate the upper plate from the sequencing cell. Take great care to avoid breaking the gel.</li>
		<li>Cut chromatography paper (Materials List) to match the gel size from the top to the bromophenol blue dye. Use a Geiger counter to confirm the approximate position of radioactively labelled RNA transcripts.</li>
		<li>Carefully cover the gel with the filter paper, and press firmly till the gel adheres to the filter paper. Cut off and discard the bottom of the gel to radioactive waste as the unincorporated NTPs run to the bottom of the gel, which can be very hot.</li>
		<li>Place a similar sized piece of filter paper on the drying bed of a vacuum-drying machine, and carefully lay the gel-coated paper onto it with the gel side up.</li>
		<li>Cover the gel with a plastic wrap and dry at 60 &#176;C for 1.5 hr.</li>
		<li>Wrap the other side of the gel coated filter paper with plastic wrap, and place on a photostimulable phosphor plate in the imaging case, with the appropriate exposure time, which can vary from 1 hr to overnight depending on the reaction efficiency.</li>
		<li>Image the phosphor plate using an imager scanner according to manufacturer&#39;s instructions. Determine the relative band intensity using ImageJ software according to the software manual.</li>
		<li>Use a Geiger counter to check the radioactive contamination in the work area, wipe the suspected items and area with tissue and a cleaning agent and dispose the tissue in the disposal container.</li>
	</ol>
	</li>
</ol>

<ol><li>Mooney, R. A., Artsimovitch, I., Landick, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Information+processing+by+RNA+polymerase%3A+recognition+of+regulatory+signals+during+RNA+chain+elongation%5BTitle%5D)+AND+%22J.+Bacteriol%22%5BJournal%5D)">Information processing by RNA polymerase: recognition of regulatory signals during RNA chain elongation.</a> J. Bacteriol. 180 (13), 3265-3275 (1998).</li>
<li>Burgess, R. R., Anthony, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((How+sigma+docks+to+RNA+polymerase+and+what+sigma+does%5BTitle%5D)+AND+%22Curr.+Opin.+Microbiol%22%5BJournal%5D)">How sigma docks to RNA polymerase and what sigma does.</a> Curr. Opin. Microbiol. 4 (2), 126-131 (2001).</li>
<li>Gusarov, I., Nudler, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Control+of+intrinsic+transcription+termination+by+N+and+NusA%3A+the+basic+mechanisms%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Control of intrinsic transcription termination by N and NusA: the basic mechanisms.</a> Cell. 107 (4), 437-449 (2001).</li>
<li>Ha, K. S., Toulokhonov, I., Vassylyev, D. G., Landick, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+NusA+N-terminal+domain+is+necessary+and+sufficient+for+enhancement+of+transcriptional+pausing+via+interaction+with+the+RNA+exit+channel+of+RNA+polymerase%5BTitle%5D)+AND+%22J.+Mol.+Biol%22%5BJournal%5D)">The NusA N-terminal domain is necessary and sufficient for enhancement of transcriptional pausing via interaction with the RNA exit channel of RNA polymerase.</a> J. Mol. Biol. 401 (5), 708-725 (2010).</li>
<li>Yang, X., Lewis, P. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+interaction+between+RNA+polymerase+and+the+elongation+factor+NusA%5BTitle%5D)+AND+%22RNA+Biol%22%5BJournal%5D)">The interaction between RNA polymerase and the elongation factor NusA.</a> RNA Biol. 7 (3), 272-275 (2010).</li>
<li>Artsimovitch, I., Henkin, T. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In+vitro+approaches+to+analysis+of+transcription+termination%5BTitle%5D)+AND+%22Methods%22%5BJournal%5D)">In vitro approaches to analysis of transcription termination.</a> Methods. 47 (1), 37-43 (2009).</li>
<li>Decker, K. B., Hinton, D. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Transcription+regulation+at+the+core%3A+Similarities+among+bacterial%2C+archaeal%2C+and+eukaryotic+RNA+polymerases%5BTitle%5D)+AND+%22Annu.+Rev.+Microbiol%22%5BJournal%5D)">Transcription regulation at the core: Similarities among bacterial, archaeal, and eukaryotic RNA polymerases.</a> Annu. Rev. Microbiol. 67, 113-139 (2013).</li>
<li>Artsimovitch, I., Vassylyev, D. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Is+it+easy+to+stop+RNA+polymerase%3F%5BTitle%5D)+AND+%22Cell+Cycle%22%5BJournal%5D)">Is it easy to stop RNA polymerase?</a> Cell Cycle. 5 (4), 399-404 (2006).</li>
<li>Murakami, K. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Structural+biology+of+bacterial+RNA+polymerase%5BTitle%5D)+AND+%22Biomolecules%22%5BJournal%5D)">Structural biology of bacterial RNA polymerase.</a> Biomolecules. 5 (2), 848-864 (2015).</li>
<li>Ma, C., Yang, X., Lewis, P. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Bacterial+transcription+as+a+target+for+antibacterial+drug+development%5BTitle%5D)+AND+%22Microbiol.+Mol.+Biol.+Rev%22%5BJournal%5D)">Bacterial transcription as a target for antibacterial drug development.</a> Microbiol. Mol. Biol. Rev. 80 (1), 139-160 (2016).</li>
<li>Yang, X., Ma, C., Lewis, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+vector+system+that+allows+simple+generation+of+mutant+Escherichia+coli+RNA+polymerase%5BTitle%5D)+AND+%22Plasmid%22%5BJournal%5D)">A vector system that allows simple generation of mutant Escherichia coli RNA polymerase.</a> Plasmid. 75, 37-41 (2014).</li>
<li>Burgess, R. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+new+method+for+the+large+scale+purification+of+Escherichia+coli+deoxyribonucleic+acid-dependent+ribonucleic+acid+polymerase%5BTitle%5D)+AND+%22J.+Biol.+Chem%22%5BJournal%5D)">A new method for the large scale purification of Escherichia coli deoxyribonucleic acid-dependent ribonucleic acid polymerase.</a> J. Biol. Chem. 244, 6160-6167 (1969).</li>
<li>Artsimovitch, I., Svetlov, V., Murakami, K. S., Landick, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Co-overexpression+of+Escherichia+coli+RNA+polymerase+subunits+allows+isolation+and+analysis+of+mutant+enzymes+lacking+lineage-specific+sequence+insertions%5BTitle%5D)+AND+%22J.+Biol.+Chem%22%5BJournal%5D)">Co-overexpression of Escherichia coli RNA polymerase subunits allows isolation and analysis of mutant enzymes lacking lineage-specific sequence insertions.</a> J. Biol. Chem. 278 (14), 12344-12355 (2003).</li>
<li>Ma, C., Yang, X., Lewis, P. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Bacterial+transcription+inhibitor+of+RNA+polymerase+holoenzyme+formation+by+structure-based+drug+design%3A+From+in+silico+screening+to+validation%5BTitle%5D)+AND+%22ACS+Infect.+Dis%22%5BJournal%5D)">Bacterial transcription inhibitor of RNA polymerase holoenzyme formation by structure-based drug design: From in silico screening to validation.</a> ACS Infect. Dis. 2, 39-46 (2016).</li>
<li>Ma, C., Mobli, M., Yang, X., Keller, A. N., King, G. F., Lewis, P. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((RNA+polymerase-induced+remodelling+of+NusA+produces+a+pause+enhancement+complex%5BTitle%5D)+AND+%22Nucleic+Acids+Res%22%5BJournal%5D)">RNA polymerase-induced remodelling of NusA produces a pause enhancement complex.</a> Nucleic Acids Res. 43 (5), 2829-2840 (2015).</li>
<li>Lewis, P. J., Marston, A. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((GFP+vectors+for+controlled+expression+and+dual+labelling+of+protein+fusions+in+Bacillus+subtilis%5BTitle%5D)+AND+%22Gene%22%5BJournal%5D)">GFP vectors for controlled expression and dual labelling of protein fusions in Bacillus subtilis.</a> Gene. 227 (1), 101-110 (1999).</li>
<li>Artsimovitch, I., Landick, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pausing+by+bacterial+RNA+polymerase+is+mediated+by+mechanistically+distinct+classes+of+signals%5BTitle%5D)+AND+%22Proc.+Natl.+Acad.+Sci%22%5BJournal%5D)">Pausing by bacterial RNA polymerase is mediated by mechanistically distinct classes of signals.</a> Proc. Natl. Acad. Sci. 97 (13), 7090-7095 (2000).</li>
<li>Vassylyev, D. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Crystal+structure+of+a+bacterial+RNA+polymerase+holoenzyme+at+2.6+%C3%85+resolution%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 Å resolution.</a> Nature. 417, 712-719 (2002).</li>
<li>Artsimovitch, I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Structural+basis+for+transcription+regulation+by+alarmone+ppGpp%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Structural basis for transcription regulation by alarmone ppGpp.</a> Cell. 117 (3), 299-310 (2004).</li>
<li>Bordier, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Inhibition+of+rifampicin-resistant+RNA+synthesis+by+rifampicin-RNA+polymerase+complexes%5BTitle%5D)+AND+%22FEBS+lett%22%5BJournal%5D)">Inhibition of rifampicin-resistant RNA synthesis by rifampicin-RNA polymerase complexes.</a> FEBS lett. 45 (1-2), 259-262 (1974).</li>
<li>Tang, G. Q., Anand, V. S., Patel, S. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Fluorescence-based+assay+to+measure+the+real-time+kinetics+of+nucleotide+incorporation+during+transcription+elongation%5BTitle%5D)+AND+%22J.+Mol.+Biol%22%5BJournal%5D)">Fluorescence-based assay to measure the real-time kinetics of nucleotide incorporation during transcription elongation.</a> J. Mol. Biol. 405 (3), 666-678 (2011).</li>
</ol>

The authors have nothing to disclose.

In all organisms, transcription is a tightly regulated process. In vitro transcription assays have been developed to provide a platform for testing the effects of transcription factors, small molecules and transcription inhibitors. In this method paper, an assay for general bacterial transcription was described. Transcription assays combined with sequencing gel electrophoresis of transcripts are very important for mechanistic studies as they allow visualization of all the transcription products along a timeline....

Transcription is the process in which RNA is synthesized from a specific DNA template. In eukaryotic cells there are three distinct RNAPs: RNAP I transcribes rRNA precursors, RNAP II is responsible for the synthesis of mRNA and certain small nuclear RNAs, and the synthesis of 5S rRNA and tRNA is performed by RNAP III. In bacteria, there is only one RNAP responsible for the transcription of all classes of RNA. There are three stages of transcription: initiation, elongation and termination. Transcription is one of the most highly regulated processes in the cell. Each stage in the transcription cycle represents a checkpoint for the regulation of gene expression1. For initiation, RNAP has to associate with a sigma factor to form holoenzyme, which is required to direct the enzyme to specific sites called promoters2 to form an open promoter complex. Subsequently, a large suite of transcription factors are responsible for the regulation of RNAP activities during the elongation and termination phases. The transcription factor examined here is the highly conserved and essential protein, NusA. It is involved in regulating transcription pausing and termination, as well as anti-termination during rRNA synthesis3-5.
In vitro transcription assays have been developed as powerful tools to study the complex regulatory steps during transcription6. In general, a linear fragment of DNA including a promoter region is required as the template for transcription. The DNA template is usually generated by PCR or by linearizing a plasmid. Purified proteins and NTPs (including one radiolabeled NTP for detection purposes) are then added and product analyzed following the required period of incubation. Using appropriate templates and reaction conditions, all stages of transcription have been examined using this approach which has enabled detailed molecular characterization of transcription over the last half century7. In combination with information on the 3-dimensional structure of RNAP it has also been possible to probe the molecular mechanism of transcription inhibition by antibiotics and antibiotic leads, and use this information in the development of new, improved drugs8-10.
In this work we provide examples of how transcription assays can be used to determine the mechanism of regulation by transcription elongation/termination factor NusA, and how the mechanism of action of a novel transcription initiation inhibitor lead can be determined.

<table><tbody><tr><td>Obtain the proteins required for transcription assay</td><td></td><td></td><td></td></tr><tr><td>&lt;em&gt;E. coli&lt;/em&gt; RNAP</td><td>Epicentre</td><td>S90250</td><td></td></tr><tr><td>Preparation of DEPC-treated water</td><td></td><td></td><td></td></tr><tr><td>diethyl pyrocarbonate (DEPC)&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>D5758</td><td></td></tr><tr><td>RNase-free water&amp;nbsp;</td><td></td><td></td><td></td></tr><tr><td>Ambion Nuclease-Free Water</td><td>ThermoFisher</td><td>AM9937</td><td></td></tr><tr><td>DNA template preparation</td><td></td><td></td><td></td></tr><tr><td>Wizard&amp;nbsp;Plus&amp;nbsp;SV Minipreps DNA Purification System</td><td>Promega</td><td>A1330</td><td></td></tr><tr><td>ACCUZYME Mix</td><td>Bioline</td><td>BIO-25028</td><td></td></tr><tr><td>PCR primers</td><td></td><td></td><td></td></tr><tr><td>Wizard SV Gel and PCR Clean-Up System&amp;nbsp;</td><td>Promega</td><td>A9281</td><td></td></tr><tr><td>NanoDrop 3300 fluorospectrometer</td><td>Thermo Scientific</td><td>ND-3300</td><td></td></tr><tr><td>NTP Preparation</td><td></td><td></td><td></td></tr><tr><td>ATP</td><td>Sigma-Aldrich&amp;nbsp;</td><td>A6559</td><td></td></tr><tr><td>UTP</td><td>Sigma-Aldrich&amp;nbsp;</td><td>U1006</td><td></td></tr><tr><td>GTP</td><td>Sigma-Aldrich&amp;nbsp;</td><td>G3776</td><td></td></tr><tr><td>CTP</td><td>Sigma-Aldrich&amp;nbsp;</td><td>C9274</td><td></td></tr><tr><td>High Purity rNTPs</td><td>GE Healthcare</td><td>27-2025-01</td><td></td></tr><tr><td>&amp;alpha;-&lt;sup&gt;32&lt;/sup&gt;P UTP&amp;nbsp;</td><td>PerkinElmer&amp;nbsp;&amp;nbsp;</td><td>BLU007C001MC</td><td>Radioactive compound</td></tr><tr><td>RNA ladder preparation&amp;nbsp;</td><td></td><td></td><td></td></tr><tr><td>Novagen Perfect RNA Marker Template Mix 0.1&amp;ndash;1 kb</td><td>Millipore</td><td>69003</td><td></td></tr><tr><td>HEPES</td><td>Sigma-Aldrich&amp;nbsp;</td><td>H7006</td><td></td></tr><tr><td>Sodium chloride</td><td>Sigma-Aldrich&amp;nbsp;</td><td>S7653</td><td></td></tr><tr><td>Magnesium chloride</td><td>Sigma-Aldrich&amp;nbsp;</td><td>M8266</td><td></td></tr><tr><td>DTT</td><td>Sigma-Aldrich</td><td>DTT-RO</td><td></td></tr><tr><td>T7 RNAP</td><td>Promega</td><td>P2075</td><td></td></tr><tr><td>Gel preparation</td><td></td><td></td><td></td></tr><tr><td>Sequi-Gen GT nucleic acid sequencing cell&amp;nbsp;</td><td>Bio-Rad&amp;nbsp;&amp;nbsp;</td><td>165-3804</td><td></td></tr><tr><td>Sigmacote&amp;nbsp;&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>SL2</td><td></td></tr><tr><td>urea&amp;nbsp;&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>U6504</td><td></td></tr><tr><td>tris(hydroxymethyl)aminomethane&amp;nbsp;&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>154563</td><td></td></tr><tr><td>boric acid&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>B7901</td><td></td></tr><tr><td>ethylenediaminetetraacetic acid&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>ED</td><td></td></tr><tr><td>40% Acrylamide/bis-acrylamide&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>A9926</td><td></td></tr><tr><td>ammonium persulfate&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>A3678</td><td></td></tr><tr><td>&lt;em&gt;N,N,N&#039;,N&#039;&lt;/em&gt;-Tetramethylethylenediamine (TEMED)</td><td>Sigma-Aldrich </td><td>T9281</td><td></td></tr><tr><td>Transcription Assay</td><td></td><td></td><td></td></tr><tr><td>Potassium chloride</td><td>Sigma-Aldrich&amp;nbsp;</td><td>P9541</td><td></td></tr><tr><td>glycerol&amp;nbsp;&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>G5516</td><td></td></tr><tr><td>rifampicin&amp;nbsp;&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>R3501</td><td></td></tr><tr><td>formamide&amp;nbsp;&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>F9037</td><td></td></tr><tr><td>bromophenol blue&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>B0126</td><td></td></tr><tr><td>xylene cyanol&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>X4126</td><td></td></tr><tr><td>heparin&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>84020</td><td></td></tr><tr><td>RNasin Ribonuclease Inhibitor</td><td>Promega</td><td>N2511</td><td></td></tr><tr><td>Transcription buffer&amp;nbsp;</td><td></td><td></td><td></td></tr><tr><td>Tris base</td><td>Sigma-Aldrich&amp;nbsp;</td><td>T1503</td><td></td></tr><tr><td>Potassium chloride</td><td>Sigma-Aldrich&amp;nbsp;</td><td>P9541</td><td></td></tr><tr><td>Magnesium chloride</td><td>Sigma-Aldrich&amp;nbsp;</td><td>M2393</td><td></td></tr><tr><td>DTT&amp;nbsp;&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>DTT-RO</td><td></td></tr><tr><td>glycerol&amp;nbsp;&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>G5516</td><td></td></tr><tr><td>Filter paper</td><td></td><td></td><td></td></tr><tr><td>Whatman&amp;nbsp;3MM Chr Chromatography Paper</td><td>Fisher Scientific</td><td>05-714-5</td><td></td></tr><tr><td>Radioactive decontaminant</td><td></td><td></td><td></td></tr><tr><td>Decon 90</td><td>decon</td><td>decon90</td><td></td></tr><tr><td>Gel Treatment</td><td></td><td></td><td></td></tr><tr><td>Typhoon Trio+ imager</td><td>GE Healthcare Life Sciences</td><td>63-0055-89</td><td></td></tr></tbody></table>

in vitro transcription assays and their application in drug discovery

In Vitro Transcription Assays and Their Application in Drug Discovery

In vitro transcription assays have been developed and widely used for many years to study the molecular mechanisms involved in transcription. This process requires multi-subunit DNA-dependent RNA polymerase (RNAP) and a series of transcription factors that act to modulate the activity of RNAP during gene expression. Sequencing gel electrophoresis of radiolabeled transcripts is used to provide detailed mechanistic information on how transcription proceeds and what parameters can affect it. In this paper we describe the protocol to study how the essential elongation factor NusA regulates transcriptional pausing, as well as a method to identify an antibacterial agent targeting transcription initiation through inhibition of RNAP holoenzyme formation. These methods can be used a as platform for the development of additional approaches to explore the mechanism of action of the transcription factors which still remain unclear, as well as new antibacterial agents targeting transcription which is an underutilized drug target in antibiotic research and development.

Transcription efficiency can be determined by measuring the level of radiation in the bands at different time points. The pausing assay to test the function of NusA factor enabled visualization of the pause, termination, and run-off products (Figure 1A). In the presence of the N-terminal domain of NusA (NusA NTD; amino acid residues 1-137), appearance of the RNA products was significantly delayed compared to the control experiment lacking NusA. Deletion of amino acid resi...

In this manuscript, we describe a protocol to functionally examine transcription and the inhibitory activity of antibacterial agents targeting bacterial transcription.

In vitro transcription assays have been developed and widely used for many years to study the molecular mechanisms involved in transcription. This process ...

The overall goal of this in vitro transcription assay is to study the complex regulatory steps during transcription by providing a platform for testing the effects of transcription factors, small molecules, and transcription inhibitors. This method can help answer key questions in molecular biology, such as the precise mechanisms associated with transcription regulation, the function of transcription factors with unknown mechanisms, and the effects of normal transcription inhibitors. The main advantage of this technique is that it allows direct visualization of all the transcription products along a timeline from a single RNA sequencing gel.Begin this procedure by cleaning the plates from a sequencing gel apparatus twice with 70%ethanol and purified water. Assemble the cell with a comb and two spacers. Dissolve 33.6 grams of urea in 22 milliliters of water and 16.4 milliliters of five times TBE buffer using a magnetic stirrer.Add 16 milliliters of a 40%acrylamide, this acrylamide solution to the urea solution, and filter through a 0.45 micrometer filter. Add to the filtered solutoin 514 microliters of a freshly prepared 10%ammonium persulfate solution. Followed by 51.4 microliters of TEMED.Gently invert the gel solution to avoid excessive aeration and inject immediately and smoothly from the bottom injection hole into the horizontally positioned pre-packed sequencing cell. Take care to avoid making bubbles during the injection. Allow the gel to completely set for one to 1.5 hours before use.To start the procedure for the formation of a transcription elongation complex, add one microliter of RNA polymerase core enzyme to a 1.5 microliter tube. Add one microliter of purified sigma 70 factor to the RNA polymerase and incubate on ice for 10 minutes to form the RNA polymerase holoenzyme. Add to the RNA polymerase holoenzyme 3 microliters of a 500 nano molar purified template DNA in transcription buffer and incubate at 37 degrees Celsius for five minutes to form the open complex.Next, prepare a mixture of reaction components by adding the following reagents to a 1.5 milliliter tube. Five microliters of 10 times transcription buffer, two microliters of 250 micromolar GTP, two microliters of 250 micromolar UTP, one microliter of one millimolar ATP, and one microliter of alpha P 32 labeled UTP. Add DEPC treated water to the mixture to 41 microliters.Transfer the mixture to the tube containing the open complex and incubate at 37 degrees Celsius for fifteen minutes to form the transcription elongation complex stopped at plus 26 nucleotide. After 15 minutes, move the reaction to room temperature and add one microliter of 2.4 milligrams per milliliter rifampicin to a final concentration of 50 micrograms per milliliter. Add one microliter of 0.1 millimolar purified NusA transcription factor to the reaction mixture and incubate for five minutes at room temperature.Add two microliters of 250 micromolars CTP to the reaction mixture to make a final volume of 50 microliters and measure the reaction time using a timer. At each time point, transfer five microliters of the reaction solution into 2 microliters of RNA Gel-loading Buffer to quench the reaction. Prior to electrophoresis of the samples, pre-run the gel for approximately 1.5 hours at 50 degrees Celsius and 50 watts in one time TBE buffer until the temperature of the gel and the buffer is stable at 50 degrees Celsius.When the pre-run is complete, heat the samples at 90 degrees Celsius for 30 seconds and move them onto ice. Load the first well on the top of the gel with two microliters of RNA ladder and then, load the samples into the wells along side the ladder. Run the gel at 50 watts and 50 degrees Celsius in one time TBE buffer for about 1.5 hours, until the bromophenol blue dye reaches about 2/3 down the gel.When the run is complete, slowly open the two gel plates and carefully separate the upper plate from the sequencing cell, taking great care to avoid breaking the gel. Cut chromatography paper to match the gel size from the top to the bromophenol blue dye. Use a Geiger counter to confirm the approximate position of radioactively labeled RNA transcripts.Carefully cover the gel with the filter paper and press firmly until the gel adheres to the filter paper. Cut off and discard the bottom of the gel as radioactive waste, since the unincorporated NTPs run to the bottom of the gel, which can be highly radioactive. Place a similar sized piece of filter paper on the drying bed of a vacuum drying machine and carefully lay the gel-coated paper onto it with the gel side up.Cover the gel with plastic wrap and dry at 60 degrees Celsius for 1.5 hours. After the gel is dry, wrap the other side of the gel-coated filter paper with plastic wrap and place a photostimulable phosphor plate in the imaging case for the appropriate exposure time. Subsequently, image the phosphor plate using an imager scanner according to the manufacturer's instructions.To test the effects of mutant NusA end terminal domain, or NTD in transcription, transcription elongation pausing assays were performed without NusA or with NusA-NTD, NusA-NTD with Helix 3 deleted, and NusA-NTD with alanine substitutions at eight residues. The pause, termination, and run-off products were successfully visualized. In the presence of NusA-NTD, appearance of the RNA products was significantly delayed compared to the control experiment lacking NusA.The pause activities of half-lives of mutant NusA-NTD relative to the wild type protein is shown. Deletion of helix 3, or alternation to alanine of a series of amino acids, resulted in the complete loss of NusA pause activity. Helix 3 residues, arginine 104 and lysine 111, were shown to be essential for NusA-NTD pause activity.In vitro transcription assays can also be used to examine the effects of newly identified bacterial transcription inhibitors, such as compound C5.Percent inhibition of transcription was determined by the RNA product relative to a control against the concentration of C5 used in the reaction. Mechanistically, addition of C5 to RNA polymerase followed by sigma 70 factor to the reaction mixture was significantly more efficient for transcription inhibition than using C5 after the formation of the RNA polymerase holoenzyme. Following this procedure, other methods like ELISA and isothermal titration calorimetry, can be preformed in order to answer additional questions, such as, how a inhibitor affects transcription.Once developed, this technique pave the way for researchers in the field of molecular or chemical biology. To explore the mechanism and related inhibitors in bacterial transcription. Don't forget that working with radioactive reagents can be extremely hazardous and precautions such as full PPE should always be used while preforming this procedure.

in-vitro-transcription-assays-and-their-application-in-drug-discovery

Research

JoVE Journal

Genetics

We developed a quantitative DNA-binding, ELISA-based assay to measure transcription factor interactions with DNA.  High specificity for the RUNX2 protein was achieved with a consensus DNA-recognition oligonucleotide and specific monoclonal antibody. Colorimetric detection with an enzyme-coupled antibody substrate reaction was monitored in real time.

A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents

Gallium(III) 5,10,15-(tris)pentafluorophenylcorrole and its freebase analogue exhibit low micromolar cell cytotoxicity. This manuscript describes an RNA transcription reaction, imaging RNA with an ethidium bromide-stained gel, and quantifying RNA with UV-Vis spectroscopy, in order to assess transcription inhibition by corroles and demonstrates a straightforward method of evaluating anticancer candidate properties.

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles

Here, real-time monitoring of tumor cell metabolism, combined with an in vivo chicken embryo chorio-allantoic membrane (CAM) model of metastasis, are used to evaluate novel anti-cancer targets/agents for their ability to sensitize tumor cells to DNA damaging chemotherapeutics.

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Here we describe a cell-based reporter gene assay as a valuable tool to screen chemical libraries for compounds modulating post-transcriptional control mechanisms exerted through 3’ UTR.

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Drug resistance to targeted therapeutics is widespread and the need to identify mechanisms of resistance--prior to or following clinical onset--is critical for guiding alternative clinical management strategies. Here, we present a protocol to couple derivation of drug-resistant lines in vitro with sequencing to expedite discovery of these mechanisms.

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

In this work we provide an experimental workflow of how active enhancers can be identified and experimentally validated.

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation

We present in the current study a novel fluorescence-based assay using lymphocytes derived from a transgenic mouse. This assay is suitable for high-throughput screening (HTS) of small molecules endowed with the capacity of either inhibiting or promoting lymphocyte activation.

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

We present a protocol to study mRNA translation regulation in poxvirus-infected cells using in vitro Transcribed RNA-based luciferase reporter assay. The assay can be used for studying translation regulation by cis-elements of an mRNA, including 5’-untranslated region (UTR) and 3’-UTR. Different translation initiation modes can also be examined using this method.

In Vitro Transcribed RNA-based Luciferase Reporter Assay to Study Translation Regulation in Poxvirus-infected Cells

Here, we present a protocol for the in vitro selection of engineered transcriptional repressors (ETRs) with high, long-term, stable, on-target silencing efficiency and low genome-wide, off-target activity. This workflow allows for reducing an initial, complex repertoire of candidate ETRs to a short list, suitable for further evaluation in therapeutically relevant settings.

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

This protocol describes a workflow from ex vivo or in vitro cell cultures to transcriptomic data pre-processing for cost-effective transcriptome-based drug screening.

Cost-Efficient Transcriptomic-Based Drug Screening

Learn in vitro transcription assays for studying bacterial transcription regulation and testing antibacterial agents. This method enables direct visualization of RNA products to evaluate inhibitor effects.

In Vitro Transcription Assays and Their Application in Drug Discovery

Explore More Videos